While its growth was overshadowed in 2025 by A.I., the biotech sector grew signifcantly and 2026 looks for the trend to ...

Half a year after being spurned by the FDA and following deep layoffs, IO Biotech has decided to close its doors for good.

​Biotechnology company Lipella Pharmaceuticals Inc. files for Chapter 11 bankruptcy months after facing Nasdaq delisting.

Adaptive Biotechnologies, a leader in immune-driven diagnostics, reported a notable insider sale amid strong one-year stock ...

After several years of IPO drought in the biotech industry, the public market is picking up again. Will the trend keep going ...

This little-known biotech could have a big hit on its hands with VK2735, a GLP-1 weight loss drug candidate.

The layoffs by Cambridge-based Takeda, affecting its Kendall Square workforce, are part of a restructuring plan to save $1.25 ...

By Marleen Kaesebier and Bhanvi Satija March 27 (Reuters) - Swiss drugmaker Novartis will buy California-based biotech ...

Tivic Health Systems is developing immune‑modulating therapies for conditions, such as radiation exposure, while expanding ...

Gross profit margin recorded 37.9%, a YOY increase of 3.3 pp Net profit recorded RMB269.3 million, a YOY increase 21.3% Adjusted non-IFRS net profit recorded RMB335.3 million, a YOY increase of nearly ...

We explore what allosteric modulators are, their benefits and drawbacks, and which candidates are currently advancing through ...